| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |